Figure 7.
Incidence of infections and mucositis according to treatment arm within/after first part of DI with doxorubicin/vincristine and dexamethasone and second part of DI with cyclophosphamide/cytarabine/6-thioguanine.
Incidence of infections and mucositis according to treatment arm within/after first part of DI with doxorubicin/vincristine and dexamethasone and second part of DI with cyclophosphamide/cytarabine/6-thioguanine.